3226 Uracil Transporter UraA
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 0 | 7.3 | 0 | q = 2.1e-4 | |
| Hydrocarbons | 1 | 0.1 | 9.68× | not tested | |
| Phenylpropanoids and polyketides | 2 | 0.3 | 6.50× | not tested | |
| Lipids and lipid-like molecules | 7 | 1.7 | 4.25× | not tested | |
| Benzenoids | 3 | 1.1 | 2.77× | not tested | |
| Organoheterocyclic compounds | 5 | 2.3 | 2.20× | not tested | |
| Organic nitrogen compounds | 1 | 0.5 | 2.12× | not tested | |
| Organic oxygen compounds | 2 | 3.0 | 0.68× | not tested | |
| Homogeneous non-metal compounds | 2 | 3.2 | 0.63× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04540 | CLR | Cholesterol | 45 |
| DB00141 | NAG | N-Acetylglucosamine | 19 |
| DB00936 | SAL | Salicylic acid | 6 |
| DB02777 | PLC | Diundecyl Phosphatidyl Choline | 6 |
| DB00126 | ASC | Ascorbic acid | 2 |
| DB00975 | H9F | Dipyridamole | 2 |
| DB02134 | XAN | Xanthine | 2 |
| DB02377 | GUN | Guanine | 2 |
| DB03419 | URA | Uracil | 2 |
| DB04552 | NFL | Niflumic acid | 2 |
| DB02451 | BNG | B-nonylglucoside | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CLR | CHOLESTEROL | 61 |
| PIO | [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate | 38 |
| CL | CHLORIDE ION | 29 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 27 |
| PLC | DIUNDECYL PHOSPHATIDYL CHOLINE | 22 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 18 |
| LBN | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine | 15 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 14 |
| AV0 | Lauryl Maltose Neopentyl Glycol | 10 |
| DMU | DECYL-BETA-D-MALTOPYRANOSIDE | 9 |
| NAmetal | SODIUM ION | 8 |
| SAL | 2-HYDROXYBENZOIC ACID | 7 |
| 4KU | 2,2'-ethane-1,2-diylbis{5-[(sulfanylmethyl)amino]benzenesulfonic acid} | 6 |
| PT5 | [(2R)-1-octadecanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propan-2-yl] (8Z)-icosa-5,8,11,14-tetraenoate | 6 |
| BNG | nonyl beta-D-glucopyranoside | 5 |
| 4DS | 4,4'-Diisothiocyano-2,2'-stilbenedisulfonic acid | 4 |
| C14 | TETRADECANE | 4 |
| D10 | DECANE | 4 |
| D12 | DODECANE | 4 |
| HP6 | HEPTANE | 4 |